S-EPMC10548284 - Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm. - OmicsDI

Unknown

Dataset Information

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm.

ABSTRACT:

SUBMITTER: Kim DH

PROVIDER: S-EPMC10548284 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature